Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients
Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients
复制标题
DOI：
10.4088/jcp.13m08820
复制
发表时间：
2014-09-01
影响因子：
5.3
通讯作者：
Lublin, Henrik
中科院分区：
文献类型：
--
作者：
Ebdrup, Bjorn H.;Knop, Filip K.;Lublin, Henrik
目的：抗精神病药物治疗与代谢副作用如体重增加和糖代谢紊乱广泛相关，但其病理生理机制尚不清楚。
Objective: Treatment with antipsychotic drugs is widely associated with metabolic side effects such as weight gain and disturbed glucose metabolism, but the pathophysiologic mechanisms are unclear.Method: Fifty nondiabetic (fasting plasma glucose